Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific numerical chromosomal aberrations induced by adriamycin.

M S Aly1, O E Othman, S M El Nahas

  • 1Zoology Department, Faculty of Science, Cairo University, Egypt.

Environmental and Molecular Mutagenesis
|April 27, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A study on IL8RB gene polymorphism as a potential immuno-compromised adherent in exaggeration of parenteral and mammo-crine oxidative stress during mastitis in buffalo.

Journal of advanced research·2017
Same author

Radiation hybrid map of buffalo chromosome 7 detects a telomeric inversion compared to cattle chromosome 6.

Animal genetics·2014
Same author

Gene mapping in the river buffalo (Bubalus bubalis L.): five syntenic groups.

Journal of animal breeding and genetics = Zeitschrift fur Tierzuchtung und Zuchtungsbiologie·2011
Same author

Use of molecular markers for the identification of River Buffalo chromosomes: chromosome one.

Journal of animal breeding and genetics = Zeitschrift fur Tierzuchtung und Zuchtungsbiologie·2011
Same author

Current status of the river buffalo (Bubalus bubalis L.) gene map.

The Journal of heredity·2001
Same author

Loss of Y chromosome in bilharzial bladder cancer.

Cancer genetics and cytogenetics·2000

Adriamycin (AM) significantly increases trisomy 7 and 17 in human lymphocytes from healthy individuals and cancer patients. However, AM does not notably elevate X or Y chromosome aneuploidy.

Area of Science:

  • Cytogenetics
  • Molecular Biology
  • Toxicology

Background:

  • Aneuploidy, an abnormal chromosome number, is linked to diseases like cancer.
  • Adriamycin (AM) is a chemotherapy drug with known genotoxic effects.
  • Investigating drug-induced aneuploidy is crucial for understanding treatment risks.

Purpose of the Study:

  • To determine if Adriamycin (AM) induces aneuploidy in human lymphocytes.
  • To assess the specific chromosome changes (7, 17, X, Y) caused by AM exposure.

Main Methods:

  • Fluorescence in situ hybridization (FISH) using chromosome-specific DNA probes.
  • Analysis of interphase human lymphocytes from healthy donors and cancer patients.
  • Quantification of aneuploidy (trisomy) for chromosomes 7, 17, X, and Y before and after AM treatment.

Related Experiment Videos

Main Results:

  • AM significantly increased trisomy 7 and trisomy 17 in lymphocytes from both healthy individuals and cancer patients.
  • Approximately 70-72% of AM-treated cells showed trisomy for chromosomes 7 and 17, compared to only 6% in untreated cells.
  • No significant increase in X or Y chromosome aneuploidy was observed following AM exposure.

Conclusions:

  • Adriamycin (AM) is a potent inducer of aneuploidy for chromosomes 7 and 17 in human lymphocytes.
  • The findings highlight AM's potential to cause specific chromosomal abnormalities, relevant for cancer therapy risk assessment.
  • AM does not appear to induce aneuploidy for sex chromosomes (X and Y) in this context.